0.00Open0.05Pre Close0 Volume47 Open Interest7.50Strike Price0.00Turnover9602.71%IV417.12%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-3DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1080Delta0.1356Gamma29.20Leverage Ratio-3.2487Theta0.0000Rho3.15Eff Leverage0.0000Vega
Immunic Stock Discussion
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...
PR Newswire· 1 min ago
get the lead out 😜
No comment yet